Clinical Trial

High-Flow Nasal Cannula After Extubation in Acute Brain Injury

Completed
View on ClinicalTrials.gov →
Summary
Patients with acute brain injury after neurosurgery are at increased risk of extubation failure after removal of the endotracheal tube. High-flow nasal cannula (HFNC) may provide better post-extubation respiratory support than conventional oxygen therapy (COT), but evidence in post-neurosurgical patients remains limited. This prospective observational study evaluated adult post-neurosurgical patients with acute brain injury who underwent planned extubation in the Surgical Intensive Care Unit of Bach Mai Hospital, Vietnam. Patients received either HFNC or COT after extubation according to routine clinical practice and the decision of the attending ICU physicians. The primary outcome was treatment failure, defined as reintubation or escalation of respiratory support within 5 days after extubation. Secondary outcomes included tracheostomy, ventilator-associated pneumonia, ICU length of stay, total duration of mechanical ventilation, and time from extubation to reintubation. Propensity score matching was used to reduce baseline imbalance between groups.
Trial Details
NCT Number NCT07664085
Lead Sponsor Bach Mai Hospital
Conditions Acute Brain Injury, Post-neurosurgical Status, Extubation Failure, Postoperative Respiratory Complications, Reintubation
Enrollment 285 participants
Start Date 2025-01-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-23